ZA983722B - Cox-2 selective carprofen for treating pain and inflammation in dogs. - Google Patents

Cox-2 selective carprofen for treating pain and inflammation in dogs.

Info

Publication number
ZA983722B
ZA983722B ZA9803722A ZA983722A ZA983722B ZA 983722 B ZA983722 B ZA 983722B ZA 9803722 A ZA9803722 A ZA 9803722A ZA 983722 A ZA983722 A ZA 983722A ZA 983722 B ZA983722 B ZA 983722B
Authority
ZA
South Africa
Prior art keywords
carprofen
cox
dogs
inflammation
selective
Prior art date
Application number
ZA9803722A
Other languages
English (en)
Inventor
Kristin Marie Lundy
Anthony Paul Ricketts
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ZA983722B publication Critical patent/ZA983722B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA9803722A 1997-05-05 1998-05-04 Cox-2 selective carprofen for treating pain and inflammation in dogs. ZA983722B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4563597P 1997-05-05 1997-05-05

Publications (1)

Publication Number Publication Date
ZA983722B true ZA983722B (en) 1999-11-04

Family

ID=21939053

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9803722A ZA983722B (en) 1997-05-05 1998-05-04 Cox-2 selective carprofen for treating pain and inflammation in dogs.

Country Status (32)

Country Link
EP (1) EP0988034A1 (fr)
JP (1) JP2000513020A (fr)
KR (2) KR20040004406A (fr)
CN (1) CN1255059A (fr)
AP (1) AP9801234A0 (fr)
AR (2) AR011726A1 (fr)
AU (1) AU6932198A (fr)
BG (1) BG103852A (fr)
BR (1) BR9808720A (fr)
CA (1) CA2288759A1 (fr)
DZ (1) DZ2479A1 (fr)
EA (1) EA003696B1 (fr)
GT (1) GT199800063A (fr)
HR (1) HRP980244A2 (fr)
HU (1) HUP0001286A3 (fr)
ID (1) ID21311A (fr)
IL (1) IL132570A0 (fr)
IS (1) IS5220A (fr)
MA (1) MA26491A1 (fr)
NO (1) NO995389L (fr)
NZ (1) NZ500183A (fr)
OA (1) OA11213A (fr)
PA (1) PA8450601A1 (fr)
PE (1) PE72599A1 (fr)
PL (1) PL337003A1 (fr)
SK (1) SK148199A3 (fr)
TN (1) TNSN98059A1 (fr)
TW (1) TW590773B (fr)
UY (1) UY24989A1 (fr)
WO (1) WO1998050033A1 (fr)
YU (1) YU55899A (fr)
ZA (1) ZA983722B (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6245797B1 (en) 1997-10-22 2001-06-12 Merck & Co., Inc. Combination therapy for reducing the risks associated with cardio-and-cerebrovascular disease
AU2003204888B2 (en) * 1998-05-22 2005-07-28 Pfizer Products Inc. Treating or Preventing the Early Stages of Degeneration of Articular Cartilage or Subchondral Bone in Mammals Using Carprofen and Derivatives
US6506785B2 (en) 1998-05-22 2003-01-14 Pfizer, Inc. Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in mammals using carprofen and derivatives
AU764872B2 (en) * 1998-10-23 2003-09-04 Merck Frosst Canada & Co. Combination product comprising an E-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use
WO2000053149A2 (fr) * 1999-03-10 2000-09-14 G.D. Searle & Co. Procede et composition se rapportant a l'administration d'un inhibiteur de la cyclo-oxygenase-2
WO2001034204A1 (fr) * 1999-11-11 2001-05-17 Eli Lilly And Company Produits composes oncolytiques destines au traitement du cancer
JP2004521856A (ja) * 2000-05-15 2004-07-22 メルク フロスト カナダ アンド カンパニー Ｃｏｘ−２選択的阻害剤およびトロンボキサン阻害剤を用いる併用療法ならびにそのための組成物
RU2003100874A (ru) 2000-06-13 2004-06-27 Вайс (Us) Болеутоляющие и противовоспалительные составы, содержащие ингибиторы циклооксигеназы-2
DE10032132A1 (de) * 2000-07-01 2002-01-17 Lohmann Therapie Syst Lts Dermales Therapeutisches System enthaltend nichtsteroidale Antiphlogistika mit selektiver COX-2-Hemmung
US7189504B2 (en) 2000-08-07 2007-03-13 Vanderbilt University Compositions and methods for detecting and quantifying COX-2 activity and 2-arachidonylglycerol metabolites
US20040209959A1 (en) * 2001-07-16 2004-10-21 Edward Hogestatt Congeners of acetaminophen and related compounds as substrates for fatty acid conjugation and their use in treatment of pain, fever and inflammation
CA2519189C (fr) 2003-05-07 2012-07-17 Osteologix A/S Sels de strontium solubles dans l'eau pour le traitement de maladies des cartilages et/ou des os
KR100780983B1 (ko) * 2003-07-31 2007-11-30 파마시아 앤드 업존 캄파니 엘엘씨 소염제의 분산성 제제
WO2006123247A2 (fr) * 2005-05-20 2006-11-23 Pfizer Limited Combinaisons synergiques
WO2008122967A2 (fr) 2007-04-04 2008-10-16 Sigmoid Pharma Limited Composition pharmaceutique orale
WO2008132707A1 (fr) 2007-04-26 2008-11-06 Sigmoid Pharma Limited Fabrication de minicapsules multiples
US9278070B2 (en) 2009-05-18 2016-03-08 Sigmoid Pharma Limited Composition comprising oil drops
EP2464341B1 (fr) 2009-08-12 2022-07-06 Sublimity Therapeutics Limited Compositions immunomodulatrices comprenant une matrice polymère et une phase huileuse
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
DK3113774T3 (da) 2014-03-06 2022-03-07 Elanco Animal Health Incorporated Sammensætninger af grapiprant og fremgangsmåder til anvendelse deraf
EA036036B1 (ru) 2014-11-07 2020-09-16 Сигмойд Фарма Лимитед Композиции, содержащие циклоспорин
US12109218B2 (en) 2014-12-09 2024-10-08 Aratana Therapeutics, Inc. Compositions of grapiprant and methods for using the same
MX2017009011A (es) * 2015-01-09 2017-10-02 Jaguar Animal Health Metodos para tratar la diarrea en animales de compañia.
JP2023520367A (ja) * 2020-03-25 2023-05-17 エスアールアイ インターナショナル リポキシゲナーゼ阻害剤
US11116737B1 (en) 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections
KR102404883B1 (ko) 2020-11-30 2022-06-07 (주)이노보테라퓨틱스 벤즈브로마론을 포함하는 켈로이드 또는 비대흉터 예방 또는 치료용 약학 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3896145A (en) * 1972-07-24 1975-07-22 Hoffmann La Roche Carbazoles
CA1319886C (fr) * 1987-02-03 1993-07-06 Alberto Ferro Solutions de micelles mixtes

Also Published As

Publication number Publication date
SK148199A3 (en) 2001-09-11
HRP980244A2 (en) 1999-02-28
JP2000513020A (ja) 2000-10-03
YU55899A (sh) 2003-08-29
HUP0001286A3 (en) 2000-12-28
KR20040004406A (ko) 2004-01-13
EA003696B1 (ru) 2003-08-28
AR039628A2 (es) 2005-03-02
BR9808720A (pt) 2000-07-11
PE72599A1 (es) 1999-08-12
NZ500183A (en) 2002-04-26
UY24989A1 (es) 2001-10-25
TNSN98059A1 (fr) 2005-03-15
CA2288759A1 (fr) 1998-11-12
KR20010012300A (ko) 2001-02-15
EP0988034A1 (fr) 2000-03-29
AR011726A1 (es) 2000-08-30
HUP0001286A2 (hu) 2000-11-28
IL132570A0 (en) 2001-03-19
EA199900895A1 (ru) 2000-06-26
GT199800063A (es) 1999-10-26
WO1998050033A1 (fr) 1998-11-12
AU6932198A (en) 1998-11-27
OA11213A (en) 2003-07-14
PA8450601A1 (es) 2000-05-24
PL337003A1 (en) 2000-07-31
DZ2479A1 (fr) 2003-02-01
AP9801234A0 (en) 1999-11-04
TW590773B (en) 2004-06-11
NO995389D0 (no) 1999-11-04
MA26491A1 (fr) 2004-12-20
ID21311A (id) 1999-05-20
IS5220A (is) 1999-10-19
BG103852A (en) 2000-06-30
CN1255059A (zh) 2000-05-31
NO995389L (no) 2000-01-04

Similar Documents

Publication Publication Date Title
ZA983722B (en) Cox-2 selective carprofen for treating pain and inflammation in dogs.
HUP0004170A3 (en) Methods and materials for treating and preventing inflammation ofmucosal tissue
AU7696098A (en) Substance p inhibitors in combination with nmda-blockers for treating pain
EP1065978A4 (fr) Dispositif therapeutique implantable et methode afferente
EP1073490A4 (fr) Dispositif d'apport medicamenteux ameliore et ses procedes d'utilisation
HUP0004105A3 (en) Method and device for sewage treatment
HK1032553A1 (en) Mixing method and mixing device
GB9919113D0 (en) Hair treatment device and method
IL138062A0 (en) Veterinary delivery device and method
EP1099370A4 (fr) Installation et procede d'elevage de betail
GB9809448D0 (en) Treatment device and method
HUP0004372A3 (en) Water treatment method and device
AU2002224051A1 (en) Excrement treating system and excrement receiving cup and treating method in excrement treating system
ZA200007111B (en) Methods and devices for providing prolonged drug therapy.
GB9820631D0 (en) Hair treatment composition, method and use
HK1019254A1 (en) Storage device and storage method.
ZA200101188B (en) DNAzymes and methods for treating restenosis.
AU5871898A (en) Microparticles and their use in cancer treatment
GB9707949D0 (en) Water treatment and delivery apparatus
AU8998898A (en) Sludge or excreta treating agent, treating method, and treating apparatus
GB2339611B (en) Water treatment and delivery apparatus
ZA995262B (en) Massage composition and method.
ZA974326B (en) Microparticles and their use in wound therapy.
GB9907879D0 (en) Hair treatment device and method
TW424591U (en) Polylone waste treatment and regeneration device